AK+ Guard study for kidney patients
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests if a device can accurately measure potassium levels in people with chronic kidney disease. It also uses an iPhone app to monitor patients remotely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 22 years or older
- You have stage 3 or 4 chronic kidney disease and are a patient at Central Jersey Kidney Care
- You have a scheduled blood test for potassium
- You are taking certain blood pressure or kidney medications, or have had high potassium in the last year
- You own an iPhone that works with the study app
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common high potassium levels are in people with chronic kidney disease who are not on dialysis. It may help find who is at risk and how to prevent it.
This study looks at how high potassium levels (hyperkalemia) in people with chronic kidney disease may affect the heart. Doctors will use echocardiograms (heart ultrasounds) to check for changes.
This study tests if careful potassium management can help people with chronic kidney disease (CKD) safely take higher doses of blood pressure medicines called ACE inhibitors or ARBs, which are known to protect the kidneys. You may be eligible if you have moderate to advanced CKD and are already on a moderate dose of one of these medications.
This trial tests if a portable ECG device can help detect high potassium levels early in people with moderate to severe chronic kidney disease. It aims to make monitoring easier without frequent blood tests.
This study looks at whether using an AI tool on ECG (heart tracing) can help doctors decide the best timing for giving medicine to lower high potassium levels in the emergency department. If you have high potassium, this could help guide your treatment to keep your heart safe.
This study tests a smartphone app designed to help people with advanced kidney disease (stage 5) manage their health at home. It may be a good fit if you have diabetes, kidney damage, or heart failure, and you are comfortable using an app on your phone or tablet.
Hear when a new Hyperkalemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.